Environmental/Airborne Allergy News

BOSTON — Symptoms improved with mepolizumab after treatment with omalizumab failed for a patient with asthma who developed allergic bronchopulmonary aspergillosis, according to a poster presented at the CHEST Annual Meeting.

ALK announced the FDA approval of its new line of allergy skin testing devices and well trays, according to a company press release.

The U.S. Environmental Protection Agency awarded the New York State Department of Health $5 million to address indoor air quality issues and greenhouse gas reduction in schools.

Healio has compiled September’s most-read news in asthma and allergy.

Children in Puerto Rico who grew up with a cat in their household were 68% less likely to develop asthma, according to a study published in Annals of Allergy, Asthma & Immunology.

SoundHealth announced the unveiling of SONUCast, which predicts allergy responses based on the shape and size of a person’s nasal cavity and sinuses.

The FDA has missed its action date to address its proposed rule banning formaldehyde and formaldehyde-releasing chemicals from hair smoothing and straightening products.

Sublingual immunotherapy for house dust mite allergy improved allergic rhinitis symptoms among children aged 1 to 4 years over 12 months, according to a study published in Pediatric Allergy and Immunology.

As fall draws near, so does the season for viruses and environmental allergens, which can trigger asthma. Experts say that with children returning to school and the season changing, allergists can expect to see an increase in patients.

SAN ANTONIO — Tricia Sowers, PhD, introduced attendees to allergenic trees along the River Walk and discussed how immunotherapy can address them at the 16th Annual Allergy, Asthma & Immunology CME Conference.